Log in
NASDAQ:DNLI

Denali Therapeutics News Headlines

$35.14
+0.35 (+1.01 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$34.34
Now: $35.14
$35.28
50-Day Range
$29.95
MA: $32.96
$38.84
52-Week Range
$12.39
Now: $35.14
$39.22
Volume279,647 shs
Average Volume653,773 shs
Market Capitalization$3.72 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.91

Headlines

Denali Therapeutics (NASDAQ DNLI) News Headlines Today

Source:
DateHeadline
BidaskClub Upgrades Denali Therapeutics (NASDAQ:DNLI) to HoldBidaskClub Upgrades Denali Therapeutics (NASDAQ:DNLI) to Hold
marketbeat.com - September 15 at 1:23 AM
Morgan Stanley Raises Denali Therapeutics (NASDAQ:DNLI) Price Target to $45.00Morgan Stanley Raises Denali Therapeutics (NASDAQ:DNLI) Price Target to $45.00
marketbeat.com - August 24 at 8:45 AM
Denali Therapeutics (NASDAQ:DNLI) Trading Down 9.3% on Insider SellingDenali Therapeutics (NASDAQ:DNLI) Trading Down 9.3% on Insider Selling
marketbeat.com - June 19 at 6:29 PM
Denali Therapeutics (NASDAQ:DNLI) Stock Price Down 5.7%Denali Therapeutics (NASDAQ:DNLI) Stock Price Down 5.7%
americanbankingnews.com - September 21 at 8:15 PM
Denali Therapeutics (NASDAQ:DNLI) and Gamida Cell (NASDAQ:GMDA) Critical ReviewDenali Therapeutics (NASDAQ:DNLI) and Gamida Cell (NASDAQ:GMDA) Critical Review
americanbankingnews.com - September 16 at 6:30 PM
Denali Therapeutics Inc (NASDAQ:DNLI) Insider Carole Ho Sells 3,689 SharesDenali Therapeutics Inc (NASDAQ:DNLI) Insider Carole Ho Sells 3,689 Shares
americanbankingnews.com - September 15 at 12:42 AM
Denali Therapeutics (NASDAQ:DNLI) Hits New 1-Year High at $36.00Denali Therapeutics (NASDAQ:DNLI) Hits New 1-Year High at $36.00
americanbankingnews.com - September 14 at 3:29 PM
Denali Therapeutics (NASDAQ:DNLI) Earns Overweight Rating from Analysts at JPMorgan Chase & Co.Denali Therapeutics (NASDAQ:DNLI) Earns Overweight Rating from Analysts at JPMorgan Chase & Co.
americanbankingnews.com - September 14 at 8:08 AM
Loss-Making Denali Therapeutics Inc. (NASDAQ:DNLI) Set To BreakevenLoss-Making Denali Therapeutics Inc. (NASDAQ:DNLI) Set To Breakeven
finance.yahoo.com - August 18 at 4:12 PM
Denali Therapeutics EPS beats by $0.04, beats on revenueDenali Therapeutics EPS beats by $0.04, beats on revenue
seekingalpha.com - August 7 at 8:41 PM
Denali Therapeutics Reports Second Quarter 2020 Financial Results and Business HighlightsDenali Therapeutics Reports Second Quarter 2020 Financial Results and Business Highlights
finance.yahoo.com - August 7 at 8:41 PM
Denali Therapeutics Inc. (DNLI) Reports Q2 Loss, Tops Revenue EstimatesDenali Therapeutics Inc. (DNLI) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 7 at 8:41 PM
Mid-Afternoon Market Update: Dow Jumps Over 100 Points; Denali Therapeutics Shares Spike HigherMid-Afternoon Market Update: Dow Jumps Over 100 Points; Denali Therapeutics Shares Spike Higher
benzinga.com - August 6 at 6:25 PM
Denali shares soar on potential $2.4 billion Parkinsons, Alzheimers deal with BiogenDenali shares soar on potential $2.4 billion Parkinson's, Alzheimer's deal with Biogen
bizjournals.com - August 6 at 6:25 PM
Denali Therapeutics stock rockets into record territory after Biogen investment and collaborationDenali Therapeutics stock rockets into record territory after Biogen investment and collaboration
msn.com - August 6 at 1:24 PM
Biogen and Denali to Collaborate on LRRK2 Program for Parkinson’s Disease and Certain TV Platform-Enabled Programs for Neurodegenerative DiseasesBiogen and Denali to Collaborate on LRRK2 Program for Parkinson’s Disease and Certain TV Platform-Enabled Programs for Neurodegenerative Diseases
finance.yahoo.com - August 6 at 1:24 PM
Denali rallies on deal with Biogen in Parkinsons diseaseDenali rallies on deal with Biogen in Parkinson's disease
seekingalpha.com - August 6 at 1:24 PM
Denali Therapeutics Takes Next Big Step in Treating ParkinsonsDenali Therapeutics Takes Next Big Step in Treating Parkinson's
msn.com - August 6 at 1:24 PM
Why Shares of Denali Therapeutics Are SkyrocketingWhy Shares of Denali Therapeutics Are Skyrocketing
msn.com - August 6 at 1:24 PM
Stock Alert: Denali Therapeutics Soars 35%Stock Alert: Denali Therapeutics Soars 35%
nasdaq.com - August 6 at 1:24 PM
Denali Therapeutics Announces Decision to Advance DNL151 into Late Stage Clinical Studies in Parkinson’s PatientsDenali Therapeutics Announces Decision to Advance DNL151 into Late Stage Clinical Studies in Parkinson’s Patients
finance.yahoo.com - August 6 at 8:23 AM
Denali announces launch of early-stage study DNL758 in COVID-19Denali announces launch of early-stage study DNL758 in COVID-19
seekingalpha.com - July 30 at 7:49 PM
Denali Therapeutics Announces Phase 1b Study by Partner Sanofi of RIPK1-Inhibitor DNL758 (SAR443122) in COVID-19 PatientsDenali Therapeutics Announces Phase 1b Study by Partner Sanofi of RIPK1-Inhibitor DNL758 (SAR443122) in COVID-19 Patients
finance.yahoo.com - July 29 at 1:02 PM
Sanofi and Denali Halt Clinical Trials of Alzheimer DrugSanofi and Denali Halt Clinical Trials of Alzheimer Drug
finance.yahoo.com - June 10 at 2:31 PM
The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological AssetThe Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset
www.msn.com - June 10 at 8:55 AM
Denali Drops 7% In After-Market On Halt Of DNL747 Drug StudyDenali Drops 7% In After-Market On Halt Of DNL747 Drug Study
finance.yahoo.com - June 10 at 8:55 AM
Denali pivots on neuro candidate on safety signalsDenali pivots on neuro candidate on safety signals
seekingalpha.com - June 9 at 7:45 PM
Denali Therapeutics Provides Broad Update on Its RIPK1 Program Partnered With SanofiDenali Therapeutics Provides Broad Update on Its RIPK1 Program Partnered With Sanofi
finance.yahoo.com - June 9 at 7:45 PM
Denali Therapeutics (DNLI) Presents At Jefferies Healthcare Conference - SlideshowDenali Therapeutics (DNLI) Presents At Jefferies Healthcare Conference - Slideshow
seekingalpha.com - June 3 at 7:03 PM
Denali Therapeutics Reaches Analyst Target PriceDenali Therapeutics Reaches Analyst Target Price
www.nasdaq.com - May 28 at 12:27 PM
How this Peninsula biotech is hurdling the blood-brain barrier to tackle diseasesHow this Peninsula biotech is hurdling the blood-brain barrier to tackle diseases
www.bizjournals.com - May 27 at 8:15 PM
Denali Therapeutics Announces Publication of Two New Papers Describing Its Blood-Brain Barrier Delivery Technology in Science Translational MedicineDenali Therapeutics Announces Publication of Two New Papers Describing Its Blood-Brain Barrier Delivery Technology in Science Translational Medicine
finance.yahoo.com - May 27 at 8:15 PM
What Makes Denali Therapeutics Inc. (DNLI) a New Buy StockWhat Makes Denali Therapeutics Inc. (DNLI) a New Buy Stock
finance.yahoo.com - May 21 at 2:12 PM
First Week of July 17th Options Trading For Denali Therapeutics (DNLI)First Week of July 17th Options Trading For Denali Therapeutics (DNLI)
www.nasdaq.com - May 19 at 3:36 PM
Analyst Estimates: Heres What Brokers Think Of Denali Therapeutics Inc. (NASDAQ:DNLI) After Its First-Quarter ReportAnalyst Estimates: Here's What Brokers Think Of Denali Therapeutics Inc. (NASDAQ:DNLI) After Its First-Quarter Report
finance.yahoo.com - May 10 at 9:32 AM
Analyst Estimates: Here's What Brokers Think Of Denali Therapeutics Inc. (NASDAQ:DNLI) After Its First-Quarter ReportAnalyst Estimates: Here's What Brokers Think Of Denali Therapeutics Inc. (NASDAQ:DNLI) After Its First-Quarter Report
finance.yahoo.com - May 10 at 9:32 AM
Denali Therapeutics EPS beats by $0.02, misses on revenueDenali Therapeutics EPS beats by $0.02, misses on revenue
seekingalpha.com - May 7 at 10:02 PM
Denali Therapeutics Inc (DNLI) Reports Q1 Loss, Lags Revenue EstimatesDenali Therapeutics Inc (DNLI) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 7 at 10:02 PM
Denali Therapeutics Reports First Quarter 2020 Financial Results and Provides COVID-19 Response UpdateDenali Therapeutics Reports First Quarter 2020 Financial Results and Provides COVID-19 Response Update
finance.yahoo.com - May 7 at 5:01 PM
Analysts Estimate Denali Therapeutics Inc.
(DNLI) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Denali Therapeutics Inc. (DNLI) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - May 7 at 1:52 AM
Denali Therapeutics Provides Pipeline and Business Update in Response to the COVID-19 PandemicDenali Therapeutics Provides Pipeline and Business Update in Response to the COVID-19 Pandemic
finance.yahoo.com - April 2 at 5:11 PM
Denali Therapeutics (DNLI) Shares Cross Above 200 DMADenali Therapeutics (DNLI) Shares Cross Above 200 DMA
www.nasdaq.com - March 26 at 5:37 PM
Goldman sees 143% upside in Amarin in premarket analyst actionGoldman sees 143% upside in Amarin in premarket analyst action
seekingalpha.com - March 13 at 8:01 AM
Denali Therapeutics (DNLI) Shares Cross Below 200 DMADenali Therapeutics (DNLI) Shares Cross Below 200 DMA
www.nasdaq.com - March 5 at 3:41 PM
Denali Therapeutics Inc. Just Reported And Analysts Have Been Cutting Their EstimatesDenali Therapeutics Inc. Just Reported And Analysts Have Been Cutting Their Estimates
finance.yahoo.com - February 29 at 1:37 PM
Denali Therapeutics Inc. (DNLI) Reports Q4 Loss, Lags Revenue EstimatesDenali Therapeutics Inc. (DNLI) Reports Q4 Loss, Lags Revenue Estimates
finance.yahoo.com - February 27 at 11:24 PM
Denali Therapeutics EPS beats by $0.05, misses on revenueDenali Therapeutics EPS beats by $0.05, misses on revenue
seekingalpha.com - February 27 at 6:24 PM
Denali Therapeutics Reports Full Year 2019 Financial Results and Business HighlightsDenali Therapeutics Reports Full Year 2019 Financial Results and Business Highlights
finance.yahoo.com - February 27 at 6:24 PM
Stifel likes Alector and Denali in premarket analyst actionStifel likes Alector and Denali in premarket analyst action
seekingalpha.com - February 19 at 9:05 AM
Denali Therapeutics Inc. (DNLI) Upgraded to Strong Buy: What Does It Mean for the Stock?Denali Therapeutics Inc. (DNLI) Upgraded to Strong Buy: What Does It Mean for the Stock?
finance.yahoo.com - February 14 at 5:02 PM
Denali Therapeutics chief medical officer sets a cultural standardDenali Therapeutics chief medical officer sets a cultural standard
finance.yahoo.com - February 14 at 5:02 PM
Has Denali Therapeutics (DNLI) Outpaced Other Medical Stocks This Year?Has Denali Therapeutics (DNLI) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - February 7 at 1:19 PM
Denali Therapeutics Announces Closing of Public Offering, Including Full Exercise of Underwriters Option to Purchase Additional SharesDenali Therapeutics Announces Closing of Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
www.marketwatch.com - January 31 at 11:46 PM
This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.